Lv3
230 积分 2021-11-02 加入
CXCR6 as a novel therapeutic target in allergic asthma
1个月前
已完结
The role of the CXCR6/CXCL16 axis in the pathogenesis of fibrotic disease
1个月前
已完结
Role of the CXCR6/CXCL16 axis in autoimmune diseases
1个月前
已完结
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
2个月前
已完结
Research progress in OX40/OX40L in allergic diseases
3个月前
已完结
Treatment of atopic dermatitis: Recently approved drugs and advanced clinical development programs
3个月前
已完结
Development of a novel humanized anti-TSLP monoclonal antibody, QX008N, and exploration of combination therapy of anti-TSLP antibody and anti-IL-4R antibody
4个月前
已完结
Emerging biological treatments for asthma
4个月前
已完结
New Targeted Therapies for Uncontrolled Asthma
4个月前
已完结
IL-33/ST2 axis in autoimmune disease
4个月前
已完结
皖公网安备34019202002308
